Daclizumab

**Definition:** An anti-TAC (INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT) humanized monoclonal antibody (immunoglobulin G1 disulfide with human-mouse monoclonal clone 1H4 light chain, dimer) that is used in the treatment of ACUTE RELAPSING MULTIPLE SCLEROSIS.

**Tree numbers:** - D12.776.124.486.485.114.224.060.766 - D12.776.124.790.651.114.224.060.766 - D12.776.377.715.548.114.224.200.766

**Synonyms:** - Dacliximab